October 20, 2021 United States Securities and...
0001624517 false 0001624517 2021-09-08 2021-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED...
0001624517 false 10/31 2021 Q3 0001624517 2020-11-01 2021-07-31 0001624517 2021-09-09 0001624517 2021-07-31 0001624517 2020-10-31...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF QUALIFICATION Date Qualified: August
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
Form 1-A Issuer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-A REGULATION A...
AUREUS, INC. One Glenlake Parkway, #650 Atlanta, Georgia 30328 T: (404) 885-6045 May 10...
PHILIP MAGRI, ESQ. 2642 NE 9th Ave., Suite #10 Fort Lauderdale, FL 33334 May 5...
(Table of Contents) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...
October 21, 2020 -- InvestorsHub NewsWire -- via Stock Investor Wire -- Cytocom, Inc. , a leading biopharmaceutical company in the area of...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.